Affordable Access

deepdyve-link
Publisher Website

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. A new drug class for the treatment of hypercholesterolemia.

Authors
  • Ortega Martínez de Victoria, Emilio1
  • 1 Servicio de Endocrinología y Nutrición, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona (UB), Barcelona, España; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, España. Electronic address: [email protected]
Type
Published Article
Journal
Endocrinologia, diabetes y nutricion
Publication Date
Jan 01, 2017
Volume
64
Issue
7
Pages
341–344
Identifiers
DOI: 10.1016/j.endinu.2017.04.005
PMID: 28745604
Source
Medline
Language
Spanish
License
Unknown
Report this publication

Statistics

Seen <100 times